Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Efficacy of Zoledronic Acid in Modic Changes-related Low Back Pain (LBP)

This study has been completed.
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Katri Koivisto, University of Oulu
ClinicalTrials.gov Identifier:
NCT01330238
First received: February 11, 2011
Last updated: January 14, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
No publications provided by University of Oulu

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):